Merrick has entered a definitive agreement to acquire AI Medical Systems for approximately CHF2.3bn ($2.3bn).
The acquisition includes AI Medical’s proprietary artificial intelligence algorithms and machine learning, which will be used to diagnose diseases in patients before they feel the symptoms, improving the survival rate.
The transaction is expected to be closed by the end of the year, subject to certain closing conditions and regulatory approvals.
Based in Switzerland, Merrick is a biotechnology manufacturing company, while AI Medical Systems is a Germany-based AI-based healthcare company.
The acquisition is part of Merrick’s expansion strategy and will provide the company with competitive advantages.
Teleflex has acquired Essential Medical for an undisclosed amount.
The acquisition will expand Teleflex’s presence in structural heart and endovascular aneurysm repair markets by the inclusion of Essential Medical’s Manta Vascular Closure Device, a system used to close large bore arteriotomies after procedures.
Teleflex aims to leverage its position in the interventional cardiology market to boost the penetration and adoption of the device globally.
Wright Medical Group has completed the acquisition of Cartiva for a cash consideration of $435m.
The two companies entered a definitive agreement for the acquisition in August.
The acquisition will add Cartiva’s Synthetic Cartilage Implant (SCI), which received pre-market approval in the US in July 2016, to Wright’s portfolio. The device has also received approvals in the EU, Canada, Brazil, Chile, and Australia.
The purchase is expected to expand Wright’s growth opportunities in the global extremities market.
